GREATHOUSE KENNETH 4
4 · Zosano Pharma Corp · Filed Jun 1, 2018
Insider Transaction Report
Form 4
GREATHOUSE KENNETH
Director
Transactions
- Award
Stock Option (right to buy)
2018-05-31+25,000→ 25,000 totalExercise: $4.24Exp: 2028-04-16→ Common Stock (25,000 underlying)
Footnotes (2)
- [F1]The option grant was approved by the compensation committee of the Company's board of directors on April 16, 2018, subject to stockholder approval of an amendment to the stock option plan under which the option was granted. The Company's stockholders approved the plan amendment on May 31, 2018.
- [F2]The shares underlying the stock option vest in equal monthly installments over a four-year period, beginning on May 16, 2018, so that all shares shall have vested on April 16, 2022.